Correlation Between CytomX Therapeutics and Kezar Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Kezar Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Kezar Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Kezar Life Sciences, you can compare the effects of market volatilities on CytomX Therapeutics and Kezar Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Kezar Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Kezar Life.

Diversification Opportunities for CytomX Therapeutics and Kezar Life

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between CytomX and Kezar is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Kezar Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kezar Life Sciences and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Kezar Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kezar Life Sciences has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Kezar Life go up and down completely randomly.

Pair Corralation between CytomX Therapeutics and Kezar Life

Given the investment horizon of 90 days CytomX Therapeutics is expected to under-perform the Kezar Life. In addition to that, CytomX Therapeutics is 2.15 times more volatile than Kezar Life Sciences. It trades about -0.21 of its total potential returns per unit of risk. Kezar Life Sciences is currently generating about -0.02 per unit of volatility. If you would invest  657.00  in Kezar Life Sciences on November 3, 2024 and sell it today you would lose (9.00) from holding Kezar Life Sciences or give up 1.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CytomX Therapeutics  vs.  Kezar Life Sciences

 Performance 
       Timeline  
CytomX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Kezar Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kezar Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

CytomX Therapeutics and Kezar Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CytomX Therapeutics and Kezar Life

The main advantage of trading using opposite CytomX Therapeutics and Kezar Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Kezar Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will offset losses from the drop in Kezar Life's long position.
The idea behind CytomX Therapeutics and Kezar Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities